Bulletin
Investor Alert

Moderna Inc.

NAS: MRNA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 27, 2022, 7:59 p.m.

/zigman2/quotes/205619834/composite

$

146.90

Change

-0.76 -0.51%

Volume

Volume 123,115

Quotes are delayed by 20 min

/zigman2/quotes/205619834/composite

Previous close

$ 135.80

$ 147.66

Change

+11.86 +8.73%

Day low

Day high

$136.59

$148.54

Open

52 week low

52 week high

$119.01

$497.49

Open

Elizabeth G. Nabel

Elizabeth G. Nabel is Member of National Academy of Sciences, Member of American Academy of Arts & Sciences, Member of National Academy of Medicine (United States), Member of Association of American Physicians and Member of American Society of Clinical Investigation and on the board of 11 other companies.

In her past career Dr. Nabel held the position of President at The Brigham & Women's Hospital, Inc., President of Brigham & Women's, Executive Vice President-Strategy at Modex Therapeutics Ltd., President for Brigham & Women’s Physicians Organization, Inc. and Professor at Harvard Medical School.

She received an undergraduate degree from St. Olaf College and a doctorate from Weill Cornell Medical College.

Transactions

Date Shares Transaction Value
04/28/2022 703   Derivative/Non-derivative trans. at $0 per share. 0
07/15/2020 73,975   Disposition at $87.84 per share. 6,497,964
07/15/2020 10,948   Derivative/Non-derivative trans. at $19.15 per share. 209,654
07/15/2020 8,376   Derivative/Non-derivative trans. at $19.15 per share. 160,400
07/15/2020 40,307   Derivative/Non-derivative trans. at $14.22 per share. 573,165
05/12/2020 30,000   Disposition at $66 per share. 1,980,000
12/11/2018 13,679   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Stéphane Bancel
Chief Executive Officer & Director
Dr. Stephen Hoge
President
Mr. David W. Meline
Chief Financial Officer
Dr. Paul Burton
Chief Medical Officer
Mr. Juan Andres
Chief Technical Operations & Quality Officer
Dr. Melanie Ivarsson
Chief Development Officer
Dr. Jacqueline Miller
Senior VP-Infectious Disease Development
Mr. Patrick Norman Bergstedt
Senior Vice President-Commercial Vaccines
Mr. Raymond C. Jordan
Chief Corporate Affairs Officer
Mr. John Lepore
Senior Vice President-Government Engagement
Dr. José M. Vega
Chief Safety Officer
Ms. Kate Cronin
Chief Brand Officer
Mr. Jonathan Hoggatt
Director-Hematology
Mr. Michael Mullette
Managing Director-Canada
Mr. Marcello Damiani
Chief Digital & Operational Excellence Officer
Ms. Lavina A. Talukdar
Senior Vice President & Head-Investor Relations
Ms. Tracey Franklin
Chief Human Resources Officer
Dr. Shannon Thyme Klinger
Secretary & Chief Legal Officer
Dr. Charbel Haber
Senior Vice President-Regulatory Affairs
Dr. Paula Hammond
Scientific Advisory Board
Dr. Noubar B. Afeyan
Chairman
Dr. Francois Nader
Independent Non-Executive Director
Dr. Sandra J. Horning
Independent Director
Ms. Elizabeth E. Tallett
Independent Director
Dr. Elizabeth G. Nabel
Independent Director
Mr. Paul L. Sagan
Independent Non-Executive Director
Dr. Robert S. Langer
Independent Non-Executive Director
Mr. Stephen A. Berenson
Independent Non-Executive Director
Link to MarketWatch's Slice.